Guangdong, China

Zhenzhen Qi

This inventor holds 1 USPTO granted patent. Top assignee: Shenzhen Zhongge Biological Technology Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhenzhen Qi. Retrieved from https://idiyas.com/inventor/zhenzhen-qi-soc2miqe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 16.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zhenzhen Qi: Innovator in Pyrazolo[1,5-α]pyridine Derivatives

Introduction

Zhenzhen Qi is a notable inventor based in Guangdong, China. She has made significant contributions to the field of biological technology, particularly in the development of innovative compounds for medical applications. Her work focuses on the treatment and prevention of diseases related to RET kinases.

Latest Patents

Zhenzhen Qi holds a patent for a pyrazolo[1,5-α]pyridine derivative, which includes a preparation method and its composition and use. This invention is particularly relevant for treating and preventing various types of RET kinases-related diseases, including those mediated by wild type, gene-fusion type, and mutant type RET kinases. The compound of formula (I) is central to her patent, showcasing her expertise in medicinal chemistry.

Career Highlights

Zhenzhen Qi is currently associated with Shenzhen Zhongge Biological Technology Co., Ltd. Her role in the company allows her to apply her innovative ideas in a practical setting, contributing to advancements in biotechnology. With a focus on developing effective treatments, she has established herself as a key figure in her field.

Collaborations

Zhenzhen Qi collaborates with talented individuals such as Jian Ma and Yu Chen. These partnerships enhance her research and development efforts, fostering a collaborative environment that drives innovation.

Conclusion

Zhenzhen Qi's work in developing pyrazolo[1,5-α]pyridine derivatives exemplifies her commitment to advancing medical science. Her contributions are paving the way for new treatments for RET kinases-related diseases, highlighting her importance in the field of biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…